Fig 4 -

<p>Incremental Cost-effectiveness scatter plot for both countries (a)India and (b) Brazil. The first two scatter plots in each figure show 1000Monte Carlo simulations for the incremental costs (USD, 2021) and incremental effectiveness in correct case diagnosed with that of Diaskintest and Cy-T...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Saima Bashir (9726310) (author)
مؤلفون آخرون: Shehzad Ali (628091) (author), Seda Yerlikaya (13966305) (author), Mary Gaeddert (591524) (author), Lara Goscé (11485929) (author), Molebogeng X. Rangaka (9258426) (author), Claudia M. Denkinger (8790434) (author)
منشور في: 2024
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
الوصف
الملخص:<p>Incremental Cost-effectiveness scatter plot for both countries (a)India and (b) Brazil. The first two scatter plots in each figure show 1000Monte Carlo simulations for the incremental costs (USD, 2021) and incremental effectiveness in correct case diagnosed with that of Diaskintest and Cy-Tb compared with TST-PPD strategy. The second two plots show 1000 Monte Carlo simulations for the incremental costs (USD, 2021) and incremental effectiveness in correct case diagnosed with that of TBF and TSPOT.TB compared with QFT-GP strategy. QFT-GP QuantiFERON TB Gold Plus, TBF TBF = Standard TB-feron Elisa, TST tuberculin skin test.</p>